Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2013 Oct:24 Suppl 6:vi149-54. doi: 10.1093/annonc/mdt242. Epub 2013 Jul 17.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Europe / epidemiology
  • Humans
  • Ki-1 Antigen / metabolism
  • Lymph Nodes / pathology
  • Lymphoma, Extranodal NK-T-Cell / diagnosis
  • Lymphoma, Extranodal NK-T-Cell / drug therapy
  • Lymphoma, Extranodal NK-T-Cell / radiotherapy
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / diagnosis
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / therapy
  • Lymphoma, T-Cell / drug therapy
  • Lymphoma, T-Cell / mortality
  • Lymphoma, T-Cell, Cutaneous / diagnosis*
  • Lymphoma, T-Cell, Cutaneous / epidemiology
  • Lymphoma, T-Cell, Cutaneous / therapy*
  • Mycosis Fungoides / diagnosis
  • Mycosis Fungoides / drug therapy
  • Mycosis Fungoides / radiotherapy
  • Neoplasm Staging
  • Panniculitis / drug therapy
  • Panniculitis / mortality
  • Positron-Emission Tomography
  • Sezary Syndrome / drug therapy
  • Sezary Syndrome / radiotherapy
  • Skin / pathology
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Ki-1 Antigen

Supplementary concepts

  • Subcutaneous panniculitis-like T-cell lymphoma